Using the patient-derived tumor fragment platform, we assessed the expression of Ki67 and found that Ki67 expression in human breast cancer fragments decreased after incubation with TIMM8A inhibitors for one week (Fig. 5F). The gene discussed is MKI67; the disease is neoplasm.